High cholesterol is a significant risk factor for developing heart and circulatory diseases. In addition to behaviour changes, there are also a number of treatment options for high cholesterol. It is important to optimise lipid therapies, and several new options are available if statins are not tolerated or effective in reducing cholesterol to target. These include Ezetimibe, Bempedoic Acid, Inclisiran and PCSK9i.

Inclisiran was added to the NICE lipid management pathway in October 2021 as a secondary prevention option for patients treated with a maximum dose of statins and LDL >2.6 mmol/L.

The number of Inclisiran doses being prescribed across SE is starting to increase, and we are keen to provide an overview of where Inclisiran fits within the NICE Lipid Management pathway, explain some of the operational considerations and share examples of patients who would benefit from Inclisiran treatment.

We will be running this webinar on two separate occasions. It is not necessary to attend both, please register for the date that is most suitable for you.

The webinar will be structured as follows:

Lipid Pathway Summary & Operational considerations - Dr Richard Blakey: GPSI Cardiology, CVD Lead Kent Surrey & Sussex Academic Health Science Network
Patient Examples - Dr Kate Shipman, Consultant Chemical Pathologist, University Hospitals Sussex
Q & A

Webinar Objectives:

Understand where Inclisiran fits within the NICE Lipid Pathway
Improve understanding of the operational considerations when providing Inclisiran
Learn about the searches that exist to identify patients eligible for Inclisiran
Hear examples of patients that would benefit from Inclisiran
An opportunity to ask questions about the implementation of Inclisiran

We previoulsy hosted this webinar on Tuesday 20th September 2022, 1-2pm. Is not necessary to attend this event if you have already attended the event on 20th September.

This event is open to all colleagues across the South East with an interest or role in lipids management, please feel free to forward this invitation to colleagues. For those who will not be able to join or have clinical commitments on either of the dates, one of the sessions will be recorded and will be made available with any resources that are also used during the session.

CVD Education Session 2022 - Inclisiran